ERBB2 and breast cancer: Elevated COX-2 expression (noted in about half of breast cancer patients) signals poor prognosis [29], associated with large tumor size, high histological grade, negative hormone receptor status, high proliferation rate, ductal type histology, high p53 expression, HER-2 oncogene amplification, and axillary node involvement.